Loading provider…
Loading provider…
Internal Medicine Physician in Monterey, CA
NPI: 1245410588Primary Employer
MONTEREY BAY ONCOLOGY A MEDICAL CORPORATION
HQ Phone
Get MD Michael's Phone NumberMobile
Get MD Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2008 - 2026

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
UC Irvine School of Medicine
medschool.uci.edu
Medical School
Until 2007
Stanford Health Care-Sponsored Stanford University
Fellowship • Hematology
2010 - 2013
Residency • Internal Medicine
2007 - 2010
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 544 | 1,388 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 411 | 1,247 |
| 3 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 386 | 1,199 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 209 | 254 |
| 5 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 170 | 345 |
Authors: Ranjana Advani, Peter Greenberg, Richard Hoppe
Journal: J Clin Oncol
Publication Date: 2013-01-07
Neoadjuvant Imatinib for Borderline Resectable GIST
Authors: M. Zach Koontz, Brendan M Visser, Pamela L. Kunz
Publication Date: 2012-12
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Exemestane, DRUG: Letrozole, DRUG: Anastrozole, DRUG: Tamoxifen, DRUG: Imlunestrant
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Abemaciclib, DRUG: Exemestane, DRUG: Fulvestrant, DRUG: Imlunestrant
Lead Sponsor: Eli Lilly and Company
Collaborators: NSABP Foundation Inc
Intervention / Treatment: DRUG: Abemaciclib, DRUG: Standard Adjuvant Endocrine Therapy